Results for tag: "Givinostat"

Givinostat is a drug used to treat musculoskeletal disorders, such as systemic sclerosis, dermatomyositis, and polymyositis. It is a histone deacetylase inhibitor, which works by blocking the activity of certain enzymes that are involved in the development of these disorders. Givinostat is approved for use in the European Union, but is not yet approved in the United States. Givinostat is used to treat a variety of musculoskeletal disorders, including systemic sclerosis, dermatomyositis, and polymyositis. It is also being studied for its potential to treat other conditions, such as systemic lupus erythematosus and rheumatoid arthritis. The Givinostat market is growing as more patients are being diagnosed with musculoskeletal disorders. The drug is being studied for its potential to treat a variety of conditions, and its approval in the European Union has increased its availability. Some companies in the Givinostat market include Italfarmaco, a pharmaceutical company based in Italy; Galapagos, a biotechnology company based in Belgium; and FibroGen, a biopharmaceutical company based in the United States. Show Less Read more